Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Lexaria Bioscience Corp
LEXX
Alternate Symbol(s):
LEXXW
Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the...
bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LEXX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(179)
•••
ranman
X
View Profile
View Bullboard History
Post by
ranman
on Apr 08, 2024 2:15pm
LD Micro Invitational XIV 2024
I'm interested to see if tomorrow's presentation motivates people to buy a few Lexaria Lexaria presents tomorrow at 10:30 am https://ldinv14.sequireevents.com/ Gatekeeper presents tomorrw at
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 02, 2024 9:00am
New Press Release - Lexaria Awarded New Patents
(TheNewswire)Lexaria receives new patents in the fields of epilepsy and anti-viral agentsKelowna, British Columbia – April 2, 2024 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces three recent...
read article.
Q Precious & Battery Metals to Drill Initial 1000 metres at La Corne and McKenzie East Gold Projects, Quebec
posted Apr 18, 2024 9:00am by
Q Precious & Battery Metals Corp
-
|
The Company is planning for an initial 1,000 metres of diamond drilling scheduled for mid- June 2024, with VMS targets on the La Corne South project at proposed depths ranging from 50 to 300 metres below surface as modelled by the EM survey and noted in historic drilling. TMC Geophysique completed deep-penetrating Pulse-EM -Time Domain Electromagnetic (TDEM) surveying on the claims that targeted ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 21, 2024 9:21am
New Press Release - Lexaria to Present at The LD Micro Invitational XIV
Kelowna, British Columbia--(Newsfile Corp. - March 21, 2024) - Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it will be presenting at the 14th Annual LD Micro Invitational at the Sofitel New York...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 14, 2024 9:21am
New Press Release - Lexaria Appoints Nelson Cabatuan as Chief Financial Officer
(TheNewswire)Kelowna, British Columbia / TheNewswire / March 14, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective...
read article.
(1909)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Mar 11, 2024 3:31pm
Some warrants exercised?
Probably $0.95 May 2023 warrants => another $482,210 US cash inflow Shs o/s Nov 30 10,311,641 Feb issue 1
...more
(35)
•••
shawk
X
View Profile
View Bullboard History
Post by
shawk
on Mar 11, 2024 2:45pm
Special Report: Lexaria has a week for the record books
449582_b11b869ac5744f18a682429ffbf12660.pdf (letstoke.biz)
(23)
•••
Star1920
X
View Profile
View Bullboard History
Post by
Star1920
on Mar 08, 2024 9:43am
Valuation
price target $12.00 | 113.14% Average based on 1 ranked analysts Last 12 MonthsNext 12 Months Mar2023Mar20242814Mar2025 Low Estimate
...more
(35)
•••
shawk
X
View Profile
View Bullboard History
Post by
shawk
on Mar 07, 2024 2:09pm
Hill Incorporated
MariMed has now rolled out improved DehydraTECH-powered products in Massachusetts, Maryland, and Delaware, with Illinois planned to launch in early 2024 as well. MariMed brands now powered by
...more
(80)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Mar 07, 2024 12:45pm
InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX)
Just In: $LEXXW InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO for Second DehydraTECH-Powered GLP-1 Human Pilot StudyLexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 07, 2024 9:06am
New Press Release - Lexaria Awards Contract For Next GLP-1 Human Pilot Study
(TheNewswire)First-ever dissolvable DehydraTECH-GLP-1 oral dose formulation to be testedRybelsus semaglutide will act as the positive controlKelowna, British Columbia / TheNewswire / March 7, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the “Company” or “Lexaria”), a global...
read article.
(4)
•••
blacktusk
X
View Profile
View Bullboard History
Post by
blacktusk
on Mar 05, 2024 6:10pm
Maxim Group increased price target to US$12
https://beststocks.com/maxim-group-analyst-increases-price-target-fo/ Maxim Group analyst Michael Okunewitch has reaffirmed his bullish stance on Lexaria Bioscience (NASDAQ: LEXX) on March 5
...more
(80)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Mar 05, 2024 1:15pm
Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGH
BREAKING NEWS: $LEXX Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1Multiple DehydraTECH-GLP-1 and DehydraTECH-CBD formulations to be tested Chronic dosing over a 12-week treatment
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 05, 2024 9:05am
New Press Release - Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1
(TheNewswire)Multiple DehydraTECH-GLP-1 and DehydraTECH-CBD formulations to be testedChronic dosing over a 12-week treatment periodWill assess weight loss and blood glucose level controlEfficacy through possible brain absorption delivery enhancement to be assessedKelowna, British Columbia...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 04, 2024 9:16am
New Press Release - 7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study
(TheNewswire)Kelowna, British Columbia – TheNewswire - March 4, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, informs that its wholly-owned and patented DehydraTECH-CBD formulation, when administered to...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 01, 2024 8:21am
New Press Release - Lexaria Announces FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial
(TheNewswire)Kelowna, British Columbia / TheNewswire / March 1, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that the U.S. Food and Drug Administration (“FDA”) has confirmed effectiveness as of...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Q Precious & Battery Metals Contracts First Class Drilling for Quebec Projects
Why the Tonopah Gold Project is One to Watch
Targeting Nevada and Ontario for the Critical Minerals Supply Chain
Asset Sale Allows Biotech Company to Refocus on the High Value Dermatological Market